Joint repair
Buuzzzzt Wrong!
Documents lodged with the Australian Securities Exchange last year by Metabolic's listed parent company, Calzada Ltd, show the company had lodged patent applications covering AOD-9604's use in cartilage and muscle repair medicines at the same time the drug was being used at Essendon.
The patent applications came after Metabolic received results of Canadian testing in animal cells that showed AOD-9604 ''has a positive (anabolic) effect on cartilage tissue formation'', according to a company statement to the ASX.
Internal Metabolic 2011 emails obtained by Fairfax Media show the company was trying to gather all data related to AOD-9604's effect on muscle cells, with its executives excited by the drug's popularity in the body-building scene and the big sums earned by Chinese black market manufacturers.
Read more: http://www.theage.com.au/afl/afl-news/bomber-woes-mount-as-drug-probe-widens-20130629-2p48d.html#ixzz2Xld206A4
Muscle growth as well. If it were only for joint problems, then only players with cartilage issues would have been treated.